Health
Mucormycosis, Relaxation of Lockdown, Vaccination Rates: COVID-19 Global Weekly Highlights – Medscape
These are the global coronavirus stories you need to know about this week.
These are the global coronavirus stories you need to know about this week.
Doctors in India are reporting a sharp increase in cases of mucormycosis in patients recovering and recovered from COVID-19, particularly among those with diabetes. It is believed that suppressed immunity resulting from use of steroids for treating moderate and severe COVID-19 may trigger this rare but deadly fungal infection.
In the UK, the alert level was reduced from 4 to 3 by the four UK CMOs. This means a COVID-19 epidemic…
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General19 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows